If you or a loved one were diagnosed with pigmentary maculopathy, pentosan polysulfate sodium (PPS) maculopathy, macular retinopathy or other form of maculopathy after taking Elmiron, you may be entitled to recover compensation from an Elmiron maculopathy lawsuit case or settlement claim.
A team of drug injury lawyers and class action lawyers is investigating potential Elmiron lawsuit and settlement cases involving individuals who were diagnosed with maculopathy after taking Elmiron.
Maculopathy is a pathologic eye condition or eye disease involving the macula (the center part of the retina of the eye) that is characterized by a loss of central vision and impairment of visual functions.
Elmiron Maculopathy Lawsuit Cases
Elmiron maculopathy lawsuit and settlement cases potentially being investigated include claims of individuals who, after taking Elmiron (pentosan polysulfate sodium), were diagnosed with maculopathy:
- Maculopathy
- Pigmentary maculopathy
- Pentosan polysulfate sodium maculopathy
- Pentosan polysulfate maculopathy
- PPS maculopathy
- Drug induced maculopathy
- Other eye injury cases
Pigmentary Maculopathy Injury Claims
There are various forms of maculopathies, including macular degeneration, pigmentary maculopathy, Stargardt macular degeneration, hereditary maculopathy, vitelliform macular dystrophy (Best Disease), macular pucker and diabetic maculopathy, among others.
Pigmentary maculopathy (PPS or pentosan polysulfate sodium maculopathy) is a form of drug-induced maculopathy that may be linked to chronic exposure to the interstitial cystitis (bladder pain syndrome) medication Elmiron (a/k/a pentosan polysulfate sodium).
Maculopathy Signs & Symptoms
Signs and symptoms of maculopathy can potentially include:
- Blurred vision
- Prolonged dark adaptation
- Metamorphopsia
- Distorted vision
- Straight lines appear wavy
- Difficulty reading
- Poor night vision (nyctalopia)
- Loss of color vision
- Impairment of depth perception
- Impaired central vision
- Scotoma (blind spot)
- Missing areas of vision
- Difficulty adjusting to low levels of light
- Hyperpigmented macular spots
- Yellowish subretinal deposits
- Patchy parafoveal RPE atrophy
- Retinal atrophy
- Cystoid macular edema (CME)
- Macular neovascularization (MNV)
- Vitelliform maculopathy
- Other maculopathy symptoms
Procedures and tests used by eye doctors and ophthamologists to diagnose pigmentary maculopathy can include, among others, medical history, family history, physical exam, eye exam, dilated fundus examination, (DFE) comprehensive retinal evaluation, functional visual tests (such as dark adaptometry, perimetry, electroretinography, and visual function questionnaires) and color fundus photography and multimodal retinal imaging such as fundus autofluorescence imaging (FAF), optical coherence tomography (OCT), and near-infrared reflectance imaging (NIR).
If you or a loved one were diagnosed with pigmentary maculopathy, pentosan polysulfate sodium maculopathy, PPS maculopathy or other maculopathy after taking Elmiron, you may be entitled to compensation from an Elmiron maculopathy lawsuit or settlement. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company or product (e.g., Elmiron) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form on the right for a free attorney review.